BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19743954)

  • 1. The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck.
    Lee CC; Lee MS; Ho HC; Hung SK; Tung YT; Chou P; Su YC
    Clin Chem Lab Med; 2009; 47(10):1277-83. PubMed ID: 19743954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma.
    Lee CC; Ho HC; Lee MS; Hung SK; Yu CC; Su YC
    Clin Chim Acta; 2010 Aug; 411(15-16):1116-21. PubMed ID: 20417195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.
    Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Jahnke K; Lang S; Schmid KW; Siffert W; Frey UH
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3203-7. PubMed ID: 18990763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis.
    Ma J; Liu Y; Huang XL; Zhang ZY; Myers JN; Neskey DM; Zhong LP
    Oral Oncol; 2012 Nov; 48(11):1076-84. PubMed ID: 22800881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases.
    Salzman R; Kanková K; Pácal L; Tomandl J; Horáková Z; Kostrica R
    Neoplasma; 2007; 54(4):321-5. PubMed ID: 17822322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of vitamin D receptor polymorphisms in head and neck squamous cell carcinoma.
    Hama T; Norizoe C; Suga H; Mimura T; Kato T; Moriyama H; Urashima M
    PLoS One; 2011; 6(12):e29634. PubMed ID: 22242137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.
    Wang L; Rodriguez M; Kim ES; Xu Y; Bekele N; El-Naggar AK; Hong WK; Mao L; Oh YW
    Int J Oncol; 2004 Oct; 25(4):993-9. PubMed ID: 15375549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
    Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially expressed serum haptoglobin alpha chain isoforms with potential application for diagnosis of head and neck cancer.
    Chen CB; Su YC; Huang TT; Ho HC; Chang YT; Tung YT; Lee WC
    Clin Chim Acta; 2008 Dec; 398(1-2):48-52. PubMed ID: 18727923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and long-term outcomes of head and neck squamous cell carcinoma after solid organ transplantation.
    Alsidawi S; Price KA; Chintakuntlawar AV; Westin GF; Garcia JJ; Ma DJ; Okuno SH
    Oral Oncol; 2017 Sep; 72():104-109. PubMed ID: 28797445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.
    Pinheiro UB; Fraga CA; Mendes DC; Farias LC; Cardoso CM; Silveira CM; D'Angelo MF; Jones KM; Santos SH; de Paula AM; Guimarães AL
    Tumour Biol; 2015 Dec; 36(12):9259-65. PubMed ID: 26099726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma.
    Téllez-Gabriel M; Arroyo-Solera I; León X; Gallardo A; López M; Céspedes MV; Casanova I; López-Pousa A; Quer M; Mangues MA; Barnadas A; Mangues R; Pavón MA
    Cancer Med; 2013 Dec; 2(6):950-63. PubMed ID: 24403269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.
    Gunawardena I; Arendse M; Jameson MB; Plank LD; Gregor RT
    ANZ J Surg; 2015 Nov; 85(11):843-8. PubMed ID: 24171785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication.
    Tai SK; Lee JI; Ang KK; El-Naggar AK; Hassan KA; Liu D; Lee JJ; Ren H; Hong WK; Mao L
    Clin Cancer Res; 2004 Aug; 10(16):5554-7. PubMed ID: 15328196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection.
    Lou J; Wang S; Wang K; Chen C; Zhao J; Guo L
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C161-7. PubMed ID: 26506869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.